Cops Want To Look At 23andMe Customers’ DNA
By Stephanie M. Lee,
BuzzFeed
| 10. 21. 2015
Untitled Document
Individuals hoping to learn about their lineage or see how closely related they are to Neanderthals aren’t the only ones interested in the DNA tests sold by 23andMe — the FBI and other law enforcement agencies are, too.
In a transparency report published Wednesday, the direct-to-consumer genetic-testing startup revealed that law enforcement officials have requested five customers’ data over the course of the company’s nearly decade-long history. 23andMe says it hasn’t provided data in any of those cases.
“We’ve successfully fought all of those requests and we’ve had to provide no information to law enforcement,” said Kate Black — who became 23andMe’s first privacy officer in February — in an interview with BuzzFeed News. “That’s something we’re really proud of. I personally am dedicated to ensuring that we never have to give that kind of information.”
The FBI maintains its own national DNA registry of convicts and arrestees, but 23andMe has more than 1 million DNA samples (a number that may grow as the company reintroduces health-related tests), many of which aren’t already part of government registries...
Related Articles
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...